Winton Group’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-8,142
Closed -$360K 1672
2020
Q2
$360K Buy
+8,142
New +$304K 0.01% 1248
2018
Q4
Sell
-22,718
Closed -$2.09M 1097
2018
Q3
$2.09M Buy
22,718
+20,388
+875% +$1.94M 0.04% 305
2018
Q2
$229K Sell
2,330
-8,247
-78% -$922K 0.01% 931
2018
Q1
$1.18M Buy
+10,577
New +$1.19M 0.03% 448

Other funds holding CMD

Winton Group's CMD Position: Q3 2020 in Review

Winton Group sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 8,142 shares — an estimated $360K sold.

Winton Group first reported a position in CMD in Q1 2018 and held it in 4 quarters. The position peaked at $2.09M in Q3 2018. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

  • Winton Group reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
  • Winton Group sold 8,142 Cantel Medical Corporation shares in Q3 2020, an estimated $360K.
  • Winton Group first reported a position in Cantel Medical Corporation in Q1 2018 and held it in 4 quarters.
  • Winton Group's Cantel Medical Corporation position peaked at $2.09M in Q3 2018.
  • 196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Winton Group's 13F filing for Q3 2020, filed 30 Oct 2020.